Animal & Veterinary
CVM Issues FY 2005 Annual Report
FDA Veterinarian Newsletter 2006 Volume XXI, No II
The Center for Veterinary Medicine (CVM) has issued its Annual Report for Fiscal Year 2005. It is the Center’s third annual report.
As it had done in previous annual reports, CVM presents a description of its organization and responsibilities (including those of the new Office of Minor Use and Minor Species Animal Drug Development); the Center’s mission, guiding principles, and strategic plan; its sphere of influence; and its stakeholders and partners.
In the report, CVM describes the “challenges and accomplishments” it faced in FY 2005, listing specific performance goals the Center worked to achieve during the year, and explains whether the Center achieved the goal or fell short.
Among the Center’s significant accomplishments are enhancements to the animal drug review process, availability of new drugs for aquaculture and other minor species, activities to reduce the risk of antimicrobial resistance, and measures to assure the safety of animal feed and control the risk of Bovine Spongiform Encephalopathy in the United States.
2006 is the centennial year for the Food and Drug Administration (FDA), and to celebrate that anniversary, the report includes historical animal drug and animal health “milestones.” For example, in a section about increasing the availability of safe and effective drugs, the report lists 1938 as a milestone year. In that year, Congress modified the Federal Food, Drug, and Cosmetic Act to provide the government authority for pre-market approval of animal drugs. Spohn’s Udder Aid, Neo-Polycin Ophthalmic, and Glover’s Imperial Dog Capsules were some of the earliest approvals under the new authority. The report added that the oldest active approval is “Sulfodene Medication for Dogs,” approved in 1943.
As in previous reports, the FY 2005 report lists the scientific publications that CVM employees have written or helped write, and it lists CVM award winners.
New in the FY 2005 report is a list, in Appendix A, of all significant regulations, guidances, and other documents CVM issued during the year. Appendix B lists all significant New Animal Drug Approvals for the year. In other appendixes, the report presents information about staff and budget levels.
The Report is available on CVM’s website. For a printed copy, contact CVM’s Communications Staff, at HFV 12, 7519 Standish Place, Rockville, MD 20855; or call 240-276-9300.
---[Caption to Annual Report cover image]---
CVM has issued its annual report for FY 2005. It is available on CVM’s website or by contacting the Center to request a hard copy of the report.
Fiscal Year 2005 (HTML Version)[ARCHIVED]